413 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author정동탁-
dc.date.accessioned2021-08-10T05:51:29Z-
dc.date.available2021-08-10T05:51:29Z-
dc.date.issued2020-06-
dc.identifier.citationJOURNAL OF CELLULAR AND MOLECULAR MEDICINE, v. 24, no. 13, page. 7214-7227en_US
dc.identifier.issn1582-1838-
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/jcmm.15251-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/163436-
dc.description.abstractExtracellular vesicles (EVs) have recently emerged as an important carrier for various genetic materials including microRNAs (miRs). Growing evidences suggested that several miRs transported by EVs were particularly involved in modulating cardiac function. However, it has remained unclear what miRs are enriched in EVs and play an important role in the pathological condition. Therefore, we established the miR expression profiles in EVs from murine normal and failing hearts and consecutively identified substantially altered miRs. In addition, we have performed bioinformatics approach to predict potential cardiac outcomes through the identification of miR targets. Conclusively, we observed approximately 63% of predicted targets were validated with previous reports. Notably, the predicted targets by this approach were often involved in both beneficial and malicious signalling pathways, which may reflect heterogeneous cellular origins of EVs in tissues. Lastly, there has been an active debate on U6 whether it is a proper control. Through further analysis of EV miR profiles, miR-676 was identified as a superior reference control due to its consistent and abundant expressions. In summary, our results contribute to identifying specific EV miRs for the potential therapeutic targets in heart failure and suggest that miR-676 as a new reference control for the EV miR studies.en_US
dc.description.sponsorshipThis work is supported by The Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the FY17, DMDRP, Career Development Award programme under Award No. W81XWH-18-1-0322. C. K was supported by the American Heart Association (AHA) 18TPA34170460 and the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the FY18, CDMRP, Investigator-Initiated Research Award: No. W81XWH-19-1-0382.en_US
dc.language.isoen_USen_US
dc.publisherWILEYen_US
dc.titleAnalysis of extracellular vesicle miRNA profiles in heart failureen_US
dc.typeArticleen_US
dc.relation.no13-
dc.relation.volume24-
dc.identifier.doi10.1111/jcmm.15251-
dc.relation.page7214-7227-
dc.relation.journalJOURNAL OF CELLULAR AND MOLECULAR MEDICINE-
dc.contributor.googleauthorOh, Jae Gyun-
dc.contributor.googleauthorLee, Philyoung-
dc.contributor.googleauthorGordon, Ronald E.-
dc.contributor.googleauthorSahoo, Susmita-
dc.contributor.googleauthorKho, Changwon-
dc.contributor.googleauthorJeong, Dongtak-
dc.relation.code2020051693-
dc.sector.campusE-
dc.sector.daehakCOLLEGE OF SCIENCE AND CONVERGENCE TECHNOLOGY[E]-
dc.sector.departmentDEPARTMENT OF MOLECULAR AND LIFE SCIENCE-
dc.identifier.pidcooljdt-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE